NO2930176T3 - - Google Patents
Info
- Publication number
- NO2930176T3 NO2930176T3 NO13862318A NO13862318A NO2930176T3 NO 2930176 T3 NO2930176 T3 NO 2930176T3 NO 13862318 A NO13862318 A NO 13862318A NO 13862318 A NO13862318 A NO 13862318A NO 2930176 T3 NO2930176 T3 NO 2930176T3
- Authority
- NO
- Norway
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012269178 | 2012-12-10 | ||
| PCT/JP2013/083022 WO2014092061A1 (ja) | 2012-12-10 | 2013-12-10 | ヒダントイン誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO2930176T3 true NO2930176T3 (no) | 2018-07-07 |
Family
ID=50934349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO13862318A NO2930176T3 (no) | 2012-12-10 | 2013-12-10 |
Country Status (35)
| Country | Link |
|---|---|
| US (5) | US9428505B2 (no) |
| EP (1) | EP2930176B1 (no) |
| JP (1) | JP5951799B2 (no) |
| KR (1) | KR102168738B1 (no) |
| CN (1) | CN104854106B (no) |
| AU (1) | AU2013358167B2 (no) |
| BR (1) | BR112015012411B1 (no) |
| CA (1) | CA2892621C (no) |
| CL (2) | CL2015001391A1 (no) |
| CR (1) | CR20150272A (no) |
| DK (1) | DK2930176T3 (no) |
| ES (1) | ES2663797T3 (no) |
| HK (1) | HK1209735A1 (no) |
| HR (1) | HRP20180647T1 (no) |
| HU (1) | HUE037530T2 (no) |
| IL (1) | IL238277B (no) |
| LT (1) | LT2930176T (no) |
| MA (1) | MA38250B1 (no) |
| MX (1) | MX2015007309A (no) |
| MY (1) | MY178583A (no) |
| NO (1) | NO2930176T3 (no) |
| NZ (1) | NZ707946A (no) |
| PE (1) | PE20151295A1 (no) |
| PH (1) | PH12015501146B1 (no) |
| PL (1) | PL2930176T3 (no) |
| PT (1) | PT2930176T (no) |
| RS (1) | RS57190B1 (no) |
| RU (1) | RU2678984C2 (no) |
| SA (1) | SA515360528B1 (no) |
| SG (1) | SG11201504204XA (no) |
| SI (1) | SI2930176T1 (no) |
| TW (1) | TWI615394B (no) |
| UA (1) | UA115072C2 (no) |
| WO (1) | WO2014092061A1 (no) |
| ZA (1) | ZA201503597B (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI496782B (zh) | 2009-04-28 | 2015-08-21 | Chugai Pharmaceutical Co Ltd | Spiro haloperidone derivatives |
| NO2930176T3 (no) * | 2012-12-10 | 2018-07-07 | ||
| EP3153166B1 (en) * | 2014-06-09 | 2022-08-03 | Chugai Seiyaku Kabushiki Kaisha | Hydantoin derivative-containing pharmaceutical composition |
| CN112770750A (zh) * | 2018-07-30 | 2021-05-07 | 中外制药株式会社 | 乙内酰脲衍生物的固体分散体 |
| CN110464002A (zh) * | 2019-09-12 | 2019-11-19 | 西南石油大学 | 一种天然冰粉的制备方法及其应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH1135470A (ja) | 1997-07-23 | 1999-02-09 | Teijin Ltd | ビタミンｄ３誘導体を含有する副甲状腺ホルモン産生促進剤 |
| DK1137640T3 (da) | 1998-12-11 | 2006-02-06 | Hoffmann La Roche | Cykliske hydrazinderivater som TNF-alfa-inhibitorer |
| US20050101574A1 (en) | 2000-08-30 | 2005-05-12 | Seiichi Ishizuka | Parathyroid hormone production inhibitors containing vitamin d3 derivatives |
| AP2001002318A0 (en) * | 2000-10-26 | 2001-12-31 | Pfizer Prod Inc | Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| SE0100902D0 (sv) | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
| AR038658A1 (es) | 2001-06-15 | 2005-01-26 | Novartis Ag | Derivados de 4-aril-2(1h) quinazolinona y 4-aril-quinazolina 2-sustituidas, un proceso para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la preparacion de un medicamento |
| WO2003105099A1 (en) * | 2002-06-06 | 2003-12-18 | Donnelly Corporation | Interior rearview mirror system with compass |
| JP2007522214A (ja) | 2004-02-11 | 2007-08-09 | スミスクライン・ビーチャム・コーポレイション | Ｐｔｈアゴニスト |
| US20070123548A1 (en) | 2004-02-11 | 2007-05-31 | Cowan David J | Pth agonists |
| JP2008515895A (ja) | 2004-10-07 | 2008-05-15 | メルク エンド カムパニー インコーポレーテッド | Ｃｇｒｐ受容体拮抗薬 |
| WO2007135417A1 (en) | 2006-05-19 | 2007-11-29 | James Black Foundation | Benzotriazepinone derivatives |
| JP2009541342A (ja) | 2006-06-20 | 2009-11-26 | ワイス | Ｋｖ１．５カリウムチャネル阻害剤 |
| JP2010529069A (ja) | 2007-06-07 | 2010-08-26 | エフ．ホフマン−ラ ロシュ アーゲー | Ｎｋ３アンタゴニストとしてのプロリンアミド誘導体 |
| JP5455922B2 (ja) | 2007-12-10 | 2014-03-26 | ノバルティス アーゲー | 有機化合物 |
| US7981904B2 (en) | 2008-03-20 | 2011-07-19 | Takeda Pharmaceutical Company Limited | Acetyl CoA carboxylase inhibitors |
| WO2010045229A2 (en) | 2008-10-13 | 2010-04-22 | University Of Rochester | Protecting and repairing cartilage and musculoskeletal soft tissues |
| TWI496782B (zh) * | 2009-04-28 | 2015-08-21 | Chugai Pharmaceutical Co Ltd | Spiro haloperidone derivatives |
| NO2930176T3 (no) * | 2012-12-10 | 2018-07-07 | ||
| EP3153166B1 (en) * | 2014-06-09 | 2022-08-03 | Chugai Seiyaku Kabushiki Kaisha | Hydantoin derivative-containing pharmaceutical composition |
-
2013
- 2013-12-10 NO NO13862318A patent/NO2930176T3/no unknown
- 2013-12-10 NZ NZ70794613A patent/NZ707946A/en unknown
- 2013-12-10 EP EP13862318.6A patent/EP2930176B1/en active Active
- 2013-12-10 KR KR1020157017844A patent/KR102168738B1/ko active IP Right Grant
- 2013-12-10 UA UAA201504548A patent/UA115072C2/uk unknown
- 2013-12-10 TW TW102145318A patent/TWI615394B/zh active
- 2013-12-10 RS RS20180517A patent/RS57190B1/sr unknown
- 2013-12-10 MX MX2015007309A patent/MX2015007309A/es active IP Right Grant
- 2013-12-10 BR BR112015012411-9A patent/BR112015012411B1/pt active IP Right Grant
- 2013-12-10 CA CA2892621A patent/CA2892621C/en active Active
- 2013-12-10 PL PL13862318T patent/PL2930176T3/pl unknown
- 2013-12-10 MA MA38250A patent/MA38250B1/fr unknown
- 2013-12-10 DK DK13862318.6T patent/DK2930176T3/en active
- 2013-12-10 WO PCT/JP2013/083022 patent/WO2014092061A1/ja active Application Filing
- 2013-12-10 LT LTEP13862318.6T patent/LT2930176T/lt unknown
- 2013-12-10 HU HUE13862318A patent/HUE037530T2/hu unknown
- 2013-12-10 PE PE2015000878A patent/PE20151295A1/es active IP Right Grant
- 2013-12-10 PT PT138623186T patent/PT2930176T/pt unknown
- 2013-12-10 RU RU2015127624A patent/RU2678984C2/ru active
- 2013-12-10 US US14/426,408 patent/US9428505B2/en active Active
- 2013-12-10 JP JP2014552040A patent/JP5951799B2/ja active Active
- 2013-12-10 SI SI201331009T patent/SI2930176T1/en unknown
- 2013-12-10 SG SG11201504204XA patent/SG11201504204XA/en unknown
- 2013-12-10 MY MYPI2015701868A patent/MY178583A/en unknown
- 2013-12-10 AU AU2013358167A patent/AU2013358167B2/en active Active
- 2013-12-10 CN CN201380064459.1A patent/CN104854106B/zh active Active
- 2013-12-10 ES ES13862318.6T patent/ES2663797T3/es active Active
-
2015
- 2015-04-14 IL IL238277A patent/IL238277B/en active IP Right Grant
- 2015-05-21 ZA ZA2015/03597A patent/ZA201503597B/en unknown
- 2015-05-21 CR CR20150272A patent/CR20150272A/es unknown
- 2015-05-22 PH PH12015501146A patent/PH12015501146B1/en unknown
- 2015-05-22 CL CL2015001391A patent/CL2015001391A1/es unknown
- 2015-06-04 SA SA515360528A patent/SA515360528B1/ar unknown
- 2015-10-23 HK HK15110436.4A patent/HK1209735A1/xx unknown
-
2016
- 2016-07-20 US US15/214,729 patent/US20160326175A1/en not_active Abandoned
-
2017
- 2017-01-11 CL CL2017000069A patent/CL2017000069A1/es unknown
- 2017-12-20 US US15/848,267 patent/US20180237436A1/en not_active Abandoned
-
2018
- 2018-04-24 HR HRP20180647TT patent/HRP20180647T1/hr unknown
-
2020
- 2020-02-28 US US16/805,204 patent/US20210024524A1/en not_active Abandoned
-
2021
- 2021-05-25 US US17/330,200 patent/US20220162208A1/en active Pending